Keith O. Webber

596 total citations
21 papers, 484 citations indexed

About

Keith O. Webber is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Keith O. Webber has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Keith O. Webber's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Keith O. Webber is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Keith O. Webber collaborates with scholars based in United States, India and Germany. Keith O. Webber's co-authors include Ira Pastan, Ulrich Brinkmann, A K Hajra, Yoram Reiter, Amiya K. Hajra, B. Lee, Chang H. Paik, Tae Moo Yoo, William C. Eckelman and Nhat Le and has published in prestigious journals such as Annals of the New York Academy of Sciences, Methods in enzymology on CD-ROM/Methods in enzymology and International Journal of Cancer.

In The Last Decade

Keith O. Webber

21 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith O. Webber United States 14 276 253 116 78 66 21 484
Judith Horev Israel 12 231 0.8× 350 1.4× 121 1.0× 94 1.2× 10 0.2× 12 584
S Hirani United States 9 76 0.3× 308 1.2× 172 1.5× 33 0.4× 37 0.6× 10 516
Yune Z. Kunes United States 5 225 0.8× 353 1.4× 83 0.7× 124 1.6× 12 0.2× 8 472
Barbara J.M. Booth United States 14 610 2.2× 437 1.7× 126 1.1× 202 2.6× 40 0.6× 21 788
Lea Olive Tchouate Gainkam Belgium 9 454 1.6× 346 1.4× 129 1.1× 205 2.6× 35 0.5× 10 666
Gunnar Palm Sweden 8 70 0.3× 328 1.3× 37 0.3× 41 0.5× 29 0.4× 9 459
B. Matthey Germany 9 175 0.6× 192 0.8× 165 1.4× 76 1.0× 69 1.0× 10 383
David Coomber Singapore 15 201 0.7× 536 2.1× 107 0.9× 296 3.8× 61 0.9× 21 728
Wenke Weidemann Germany 12 98 0.4× 455 1.8× 103 0.9× 25 0.3× 45 0.7× 16 537
Fritz Rudert Germany 14 120 0.4× 523 2.1× 120 1.0× 96 1.2× 13 0.2× 21 705

Countries citing papers authored by Keith O. Webber

Since Specialization
Citations

This map shows the geographic impact of Keith O. Webber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith O. Webber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith O. Webber more than expected).

Fields of papers citing papers by Keith O. Webber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith O. Webber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith O. Webber. The network helps show where Keith O. Webber may publish in the future.

Co-authorship network of co-authors of Keith O. Webber

This figure shows the co-authorship network connecting the top 25 collaborators of Keith O. Webber. A scholar is included among the top collaborators of Keith O. Webber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith O. Webber. Keith O. Webber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinoshita, Hiroshi, et al.. (2024). T CELL IMMUNE RESPONSE TO INFLUENZA VACCINATION WHEN ADMINISTERED BEFORE AND AFTER AUTOLOGOUS CAR-T CELL THERAPY. Cytotherapy. 26(6). S201–S202. 1 indexed citations
2.
Stein, Kathryn E. & Keith O. Webber. (2001). The regulation of biologic products derived from bioengineered plants. Current Opinion in Biotechnology. 12(3). 308–311. 20 indexed citations
3.
Brinkmann, Ulrich, Keith O. Webber, Angelina Di Carlo, et al.. (1997). Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancers. International Journal of Cancer. 71(4). 638–644. 13 indexed citations
4.
Kobayashi, Hiroyuki, Tae Moo Yoo, Mi-Kyoung Kim, et al.. (1997). Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.. PubMed. 57(10). 1955–61. 7 indexed citations
5.
Yoo, Tae Moo, Hye Kyung Chang, Chang Won Choi, et al.. (1997). Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.. PubMed. 38(2). 294–300. 17 indexed citations
6.
Kobayashi, Hisataka, Tae Moo Yoo, Ivana K. Kim, et al.. (1996). L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.. PubMed. 56(16). 3788–95. 61 indexed citations
7.
Scherf, Uwe, Itai Benhar, Keith O. Webber, Ira Pastan, & Ulrich Brinkmann. (1996). Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.. PubMed. 2(9). 1523–31. 26 indexed citations
8.
Webber, Keith O., Robert J. Kreitman, & I Pastan. (1995). Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.. PubMed. 55(2). 318–23. 15 indexed citations
9.
Nirenberg, Marshall W., et al.. (1995). The NK‐2 Homeobox Gene and the Early Development of the Central Nervous System of Drosophila. Annals of the New York Academy of Sciences. 758(1). 224–242. 28 indexed citations
10.
11.
Choi, Chanjoong, L. Láng, Jung Tae Lee, et al.. (1995). Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.. PubMed. 55(22). 5323–9. 38 indexed citations
12.
13.
Benhar, Itai, Ulrich Brinkmann, Keith O. Webber, & I Pastan. (1994). Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization. Bioconjugate Chemistry. 5(4). 321–326. 9 indexed citations
14.
Choe, Moran, Keith O. Webber, & Ira Pastan. (1994). B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.. PubMed. 54(13). 3460–7. 14 indexed citations
15.
Webber, Keith O. & A K Hajra. (1993). Purification of Dihydroxyacetone Phosphate Acyltransferase from Guinea Pig Liver Peroxisomes. Archives of Biochemistry and Biophysics. 300(1). 88–97. 36 indexed citations
16.
Webber, Keith O. & Amiya K. Hajra. (1992). [10] Dihydroxyacetone phosphate acyltransferase. Methods in enzymology on CD-ROM/Methods in enzymology. 209. 92–98. 15 indexed citations
17.
Webber, Keith O.. (1988). Studies of dihydroxyacetone phosphate acyltransferase.. Deep Blue (University of Michigan). 1 indexed citations
18.
Hajra, A K, Shuichi Horie, & Keith O. Webber. (1988). The role of peroxisomes in glycerol ether lipid metabolism.. PubMed. 282. 99–116. 10 indexed citations
19.
Webber, Keith O., Nabanita S. Datta, & Amiya K. Hajra. (1987). Properties of the enzymes catalyzing the biosynthesis of lysophosphatidate and its ether analog in cultured fibroblasts from Zellweger syndrome patients and normal controls. Archives of Biochemistry and Biophysics. 254(2). 611–620. 18 indexed citations
20.
Webber, Keith O., H. Sund, & K. Wallenfels. (1963). The Subunits of the β‐Galactosidase from Escherichia coli. Angewandte Chemie International Edition in English. 2(8). 481–481. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith Horev Breakdown of academic impact, for papers by S Hirani Breakdown of academic impact, for papers by Yune Z. Kunes Breakdown of academic impact, for papers by Barbara J.M. Booth Breakdown of academic impact, for papers by Lea Olive Tchouate Gainkam Breakdown of academic impact, for papers by Gunnar Palm Breakdown of academic impact, for papers by B. Matthey Breakdown of academic impact, for papers by David Coomber Breakdown of academic impact, for papers by Wenke Weidemann Breakdown of academic impact, for papers by Fritz Rudert
Rankless by CCL
2026